肝细胞癌
病态的
医学
肿瘤科
免疫检查点
完全响应
内科学
癌
免疫系统
癌症研究
免疫疗法
化疗
免疫学
作者
Antonio D’Alessio,Bernardo Stefanini,Julia Blanter,Benjamin Adegbite,Fionnuala Crowley,Vincent Yip,Sarah Slater,Claudia Angela Maria Fulgenzi,Ciro Celsa,Giulia Francesca Manfredi,Madhava Pai,Robert Goldin,Stephen C. Ward,Maria Isabel Fiel,Daniel Shu,Yung‐Yeh Su,Alessio Cortellini,Marina Baretti,Robert Anders,Mark Yarchoan,Chiun Hsu,Thomas U. Marron,David J. Pinato
标识
DOI:10.1016/s1470-2045(24)00457-1
摘要
Neoadjuvant use of immune checkpoint inhibitors (ICIs) before liver resection results in pathological tumour regression in patients with hepatocellular carcinoma. We aimed to describe the characteristics of pathological responses after preoperative ICI therapy for hepatocellular carcinoma and to evaluate the association between the depth of tumour regression and relapse-free survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI